美国一家高科技调查公司最近汇总的一项美国高血脂药品市场调查报告指出,为防止高血脂转变成高血压,美国医治高血脂药物市场将迅速扩大。报告说,1999年美国需治疗的高血脂患者为2 400万人,高血脂药物市场规模75亿美元,2006年患者数量将增加到2 760万人,药物市场规模将扩大到131 A recent report by a high-tech research firm in the United States that reports on the hyperlipidemic drug market in the United States points out that in order to prevent the conversion of hyperlipidemia to high blood pressure, the market for the hyperlipidemic drug in the United States will rapidly expand. The report said that in 2004, the number of patients with hyperlipidemia needing treatment in the United States was 24 million, the market size of the hyperlipidemic drug was 7.5 billion U.S. dollars, the number of patients will increase to 27.6 million in 2006 and the drug market will be expanded to 131